Fulgent Genetics, Inc. (FLGT): Gross Profit
$130.88M
Year ended 2025-12-31
$115.26M
Trailing 12 months to 2026-06-30
-29.1%
3-year compound annual growth
-17.0%
5-year compound annual growth
+40.1%
10-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $130.88M | +22.1% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $107.22M | +2.6% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $104.46M | -71.5% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $366.90M | -52.8% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $777.05M | +134.1% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $331.90M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $18.42M | +72.9% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $10.65M | +4.7% | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | $10.18M | -11.9% | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $11.55M | +156.4% | 2018-03-20, From 2016-01-01 |
| 2015-12-31 | $4.51M | n/m | 2017-03-17, From 2015-01-01 |
| 2014-12-31 | $342.0K | n/a | 2017-03-17, From 2014-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $130.88M | +22.1% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $208.46M | +157.6% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $273.20M | +0.5% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $362.53M | +21.6% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $633.01M | +40.9% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $15.78M | -41.2% |
| Exagen Inc. (XGN) | 2025-12-31 | $38.80M | +17.2% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $5.06M | -44.9% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $3.67B | +13.0% |
Compare FLGT, BLLN, CSTL, VCYT side by side · Screen every company in Services-Medical Laboratories ↗